Equities

HitGen Inc

688222:SHH

HitGen Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)8.56
  • Today's Change-5.24 / -37.97%
  • Shares traded3.39m
  • 1 Year change-48.65%
  • Beta1.1155
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

HitGen Inc is a China-based company mainly engaged in the early research and development of original innovative drugs. The Company focuses on the research and creation of deoxyribonucleic acid encoded compound library (DEL) technology, research and development of hit compounds and lead compounds. The Company mainly provides DEL screening services, DEL library customization services, chemical synthesis services and transfer of new drug research and development projects. The Company conducts its businesses within the domestic market and to overseas markets.

  • Revenue in CNY (TTM)423.87m
  • Net income in CNY52.55m
  • Incorporated2012
  • Employees452.00
  • Location
    HitGen IncBlock 6,No.8 Huigu East 1st Road, Tianfu InternaCHENGDU 610200ChinaCHN
  • Phone+86 2 885197385
  • Fax+86 2 883310298
  • Websitehttps://www.hitgen.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Qingdao Vland Biotech INC1.26bn66.23m3.83bn1.57k57.552.22--3.030.26310.26315.026.830.4253.783.76805,143.803.255.785.097.8944.9846.137.6510.340.924811.630.290433.593.078.0515.56-0.650724.68-6.89
Hinova Pharmaceuticals Inc109.74k-210.18m3.91bn179.00--3.18--35,666.91-2.12-2.120.001112.440.000077.120.0805613.07-14.10-31.86-15.71-37.18-450.31---191,529.30-25,578.246.38--0.0457---100.00--2.44--124.37--
Bide Pharmatech Co Ltd1.10bn80.03m4.36bn846.0053.452.18--3.970.89830.898312.2521.980.46080.93594.511,298,144.003.34--3.82--40.11--7.25--4.59--0.0492--30.94---24.94------
Shanghai Aladdin Biochemical Tech Co Ltd497.71m103.71m4.51bn566.0036.634.34--9.060.44390.44391.983.750.31030.38189.08879,345.607.208.838.229.6161.5761.4923.2126.853.10113.470.278145.716.5519.36-7.489.9531.41--
Jiangsu Yahong Meditech Co Ltd149.71m-403.23m4.69bn394.00--2.25--31.30-0.7074-0.70740.26273.650.059816.646.92379,971.80-16.14-15.80-17.15-16.4878.6355.32-269.87-9,445.918.97--0.0599--52,594.79---62.42--64.28--
Beijing Kawin Technol Sha-hld Co Ltd1.42bn134.34m4.84bn584.0034.652.61--3.410.81750.81758.5310.870.57361.803.272,431,971.006.495.318.526.7681.8086.0211.318.102.91--0.14143.8221.7314.8739.7121.0425.01--
Beijing Sun-Novo Pharma Research Co Ltd1.16bn221.37m5.20bn1.39k23.504.60--4.501.981.9810.3310.100.607935.951.77844,377.1011.2512.9918.7621.7053.3053.9318.5021.341.8629.920.306810.7437.7647.2218.0854.9034.77--
Shanghai Medicilon Inc984.17m-276.79m5.45bn2.42k--2.32--5.54-2.01-2.017.2317.460.30296.901.27378,525.60-8.529.34-10.6611.730.644336.71-28.1214.932.64--0.114720.18-17.6833.26-109.82--23.60--
GemPharmatech Co Ltd677.34m139.41m5.88bn1.51k41.832.76--8.690.3430.3431.655.200.27034.542.06449,761.405.569.456.3911.1363.0470.2120.5828.164.74--0.050914.6820.4563.48-3.48--141.38--
HitGen Inc423.87m52.55m5.92bn452.00112.454.30--13.970.13140.13141.063.440.2487.104.55937,755.302.994.633.165.1051.2358.8912.0520.6616.1538.230.139119.1412.6419.6961.16-1.96-6.12--
InventisBio Co Ltd77.51m-348.02m6.26bn221.00--3.61--80.80-0.6064-0.60640.13463.010.0383--0.5855350,739.20-17.19---18.36--90.80---448.98------0.0138------41.26------
Data as of Sep 13 2024. Currency figures normalised to HitGen Inc's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

1.24%Per cent of shares held by top holders
HolderShares% Held
Da Cheng Fund Management Co., Ltd.as of 30 Jun 20241.69m0.42%
China Universal Asset Management Co., Ltd.as of 30 Jun 20241.02m0.26%
Zhong Ou Asset Management Co., Ltdas of 30 Jun 2024750.74k0.19%
Bosera Asset Management Co., Ltd.as of 30 Jun 2024588.14k0.15%
E Fund Management Co., Ltd.as of 30 Sep 2024342.85k0.09%
Cinda Fund Management Co. Ltd.as of 30 Jun 2024145.72k0.04%
GF Fund Management Co., Ltd.as of 30 Jun 2024136.78k0.03%
Essence Fund Co., Ltd.as of 30 Jun 2024118.41k0.03%
SSgA Funds Management, Inc.as of 03 Oct 2024101.69k0.03%
Tian Hong Asset Management Co., Ltd.as of 30 Jun 202471.00k0.02%
More ▼
Data from 30 Jun 2024 - 29 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.